MeSH D006934 - hypercalcemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Zoledronic acid | Zoledronic acid Teva |  | 2012-08-16 |  |  |
| Zoledronic acid | Zoledronic acid Teva Generics |  | 2014-03-27 |  |  | |
| Zoledronic acid | Zoledronic acid Teva Pharma |  | 2012-08-15 |  |  | |
| Novast Laboratories | Zoledronic acid | Zoledronic Acid |  | 2020-02-19 |  |  |
| Mylan | Cinacalcet | Cinacalcet Mylan |  | 2015-11-19 |  |  |
| Zoledronic acid | Zoledronic Acid |  | 2013-03-04 |  |  | |
| Zoledronic acid | Zoledronic acid Mylan |  | 2012-08-23 |  |  | |
| Roche | Ibandronic acid | Destara |  | 1996-06-25 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%4/4
Phase 2
75%6/8
Phase 3
92%23/25
Approved: 17Overall Success rate: 69%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use